Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study

Long-acting injectable second-generation antipsychotics (LAI-SGA) are typically used to maintain treatment adherence in patients with chronic schizophrenia. Recent research suggests that they may also provide an effective treatment strategy for patients with early-phase disease. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Corigliano, Valentina, Comparelli, Anna, Mancinelli, Iginia, Montalbani, Benedetta, Lamis, Dorian A., De Carolis, Antonella, Erbuto, Denise, Girardi, Paolo, Pompili, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136552/
https://www.ncbi.nlm.nih.gov/pubmed/30245878
http://dx.doi.org/10.1155/2018/4834135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136552/
https://www.ncbi.nlm.nih.gov/pubmed/30245878
http://dx.doi.org/10.1155/2018/4834135

Ejemplares similares